Healthcare provider Aster DM Healthcare has signed a Memorandum of Understanding (MoU) with biotechnology specialist Roche Diagnostics as the strategic partner across the United Arab Emirates (UAE), the Kingdom of Saudi Arabia (KSA), Qatar and Oman
The partnership between these two leading healthcare companies will enable Aster DM Healthcare’s hospitals, clinics and laboratories across the region to adopt the latest diagnostic innovations and solutions that would bring in fast and efficient systems to support doctors in providing optimal treatment solutions to their patients.
This also includes the provision of antibody COVID-19 testing, digital solutions, as well as automated laboratory solutions that will further enable Aster facilities to deliver high-quality and precise patient results in the shortest time possible, while boosting capabilities to drive operational efficiency essential to meet the rising demand for diagnostics in this pandemic and beyond.
The Aster laboratory consolidation project is aimed at integrating future-ready systems within the company’s expansive network of 13 hospitals, 106 clinics and laboratories in the GCC. Aimed at driving precision in diagnostics with speed and operational efficiency, the project will further strengthen the company’s ability to identify and immediately serve patient needs.
Through the use of Roche’s latest diagnostic solutions, Aster DM Healthcare’s facilities will be able to enhance capacity to test for multiple diseases by taking minimal samples from patients. This will especially be of help for more vulnerable patients such as the elderly, children, and those living with conditions such as haemophilia or other blood diseases were taking a blood sample is cumbersome and could potentially be dangerous.
Furthermore, the partnership will allow both Aster Hospitals and Roche to continue fulfilling their commitment towards the prevention, diagnosis, and treatment of various disease areas, including cardiovascular health, women’s health, infectious diseases. In doing so, the companies aim to support the welfare of the regional community and provide patients across the Middle East with world-class healthcare.
